TrademarkDir
FOUNDATIONONE CDX
LIVE

Serial Number

87386237

Owner

Foundation Medicine, Inc.

Attorney

Douglas R. Wolf

Filing Date

Mar 27, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FOUNDATIONONE CDX Trademark

Serial Number: 87386237 • Registration: 5591134

FOUNDATIONONE CDX is a trademark filed by Foundation Medicine, Inc. on March 27, 2017. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Foundation Medicine, Inc. (53 trademarks)

One Kendall Square, Suite B6501
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

March 27, 2017

Registration Date

October 23, 2018

Published for Opposition

January 23, 2018

Goods & Services

Genomic and molecular medical testing for cancer and other diagnostic or treatment purposes; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 21, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2024 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 6, 2024 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Feb 6, 2024 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 6, 2024 APRE
TEAS SECTION 8 RECEIVED
Dec 4, 2023 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 23, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2022 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 2, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 2, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Oct 23, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 20, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 19, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 5, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 5, 2018 AITU
USE AMENDMENT FILED
Aug 6, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 6, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 17, 2018 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 3, 2018 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 21, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 7, 2017 CNRT
ASSIGNED TO EXAMINER
May 30, 2017 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Mar 31, 2017 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 30, 2017 NWOS

Related Trademarks

More from this Owner

FOUNDATIONONE GERMLINE

FOUNDATIONONE GERMLINE

FOUNDATIONONE GERMLINE MORE

FOUNDATIONONE GERMLINE MORE

FOUNDATIONONE PGX

FOUNDATIONONE PGX

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

FOUNDATIONPLANNER

FOUNDATIONPLANNER